103 studies found for:    new onset type 1 diabetes
Show Display Options
Rank Status Study
21 Not yet recruiting A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP);   Drug: Placebo
22 Suspended A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Alpha 1-Antitrypsin;   Biological: Alpha-1 Antitrypsin
23 Completed
Has Results
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Anti-CD3 mAb;   Other: Diabetes Standard of Care Treatment;   Dietary Supplement: Iron supplementation
24 Withdrawn A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
Condition: New Onset Type 1 Diabetes Mellitus
Intervention: Drug: Campath 1H® (Alemtuzumab)
25 Unknown  Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
26 Active, not recruiting Inducing Remission in Type 1 Diabetes With Alefacept
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: alefacept;   Drug: placebo (saline)
27 Completed Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Anti-CD20 (rituximab)
28 Completed Effects of Recombinant Human Glutamic Acid Decarboxylase . . .
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: GAD-Alum;   Drug: Aluminum hydroxide
29 Active, not recruiting Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Pro insulin peptide;   Drug: Saline
30 Recruiting Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Secukinumab;   Drug: Placebo
31 Not yet recruiting Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
32 Completed Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Vitamin D
33 Unknown  Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Biological: Diabetes-suppressive dendritic cell vaccine;   Biological: control dendritic cells
34 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
35 Not yet recruiting Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy
Condition: Treatment of Type I Diabetes Mellitus.
Intervention: Biological: Biological
36 Completed Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Cholecalciferol
37 Recruiting Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Gamma Aminobutyric Acid (GABA);   Drug: Placebo
38 Completed Proleukin and Rapamune in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: IL-2;   Drug: sirolimus
39 Completed Low Dose Cyclosporin and Methotrexate Therapy in Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: cyclosporin and methotrexate
40 Not yet recruiting The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
Condition: Type 1 Diabetes
Interventions: Drug: Oral Cyclosporine A and Oral Lansoprazole;   Drug: Oral Placebos

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years